News & HighlightsNews
Research on repetitive worm behavior may have implications for understanding human disease
Studying microscopic worms, Rockefeller scientists have identified a brain circuit that drives repetitive behavior—providing potential clues for understanding some human psychiatric conditions.
Jue Chen and Luciano Marraffini elected to National Academy of Sciences
Election to the National Academy of Sciences is one of the most prestigious honors a scientist can receive; including Chen and Marraffini, the number of current Rockefeller scientists who are members of the elite organization stands at 38, or nearly half the faculty.
Drugs from dirt 
Therapeutics has gone underground. From one bag of soil, chemists can now procure millions of microbial molecules. Any one could be tomorrow’s lifesaving medicine.
Study pinpoints what causes relapse after cancer immunotherapy
In many cancer patients who have been treated with immunotherapy, the tumor comes back. New research identifies the cells responsible for thwarting the treatment and offers new insights into how they do it.
Gene-editing technique opens door for HIV vaccine
Researchers successfully modified immune cells to produce antibodies that fight HIV. This strategy could eventually be used to develop a vaccine against the virus, among other conditions.
Rockefeller creativity on display at the 21st annual employee art show
This year’s show featured portraiture, travel photography, collage, and other mediums.
Celebrating and remembering Paul Greengard, a pioneering neuroscientist and Nobel laureate
Greengard revolutionized our understanding of how brain cells communicate with each other and contributed to major advances in the treatment of a wide range of neurological and psychiatric diseases. He died April 13 at the age of 93.
New microscopy technique peers deep into the brain
Using new imaging technology, researchers can now record the activity of large populations of brain cells with unprecedented speed, and at new depths.
New hope for treating a childhood brain cancer
Recent research has shown that a drug known as MI-2 can kill cells that cause a fatal brain cancer. But only now have scientists been able to explain how the compound works: by targeting cholesterol production in tumors.
New approach to treating gastrointestinal disease patches up leaky intestines
Researchers have discovered a new compound that helps fortify the intestine's inner lining, which becomes porous in inflammatory bowel diseases.  
View
View